Study ID: PM032
Study Title
- Therapy Optimization in Multiple Sclerosis (MS)
Teva Identifier
- PM032
ClinicalTrials.gov Identifier
- NCT00819000
Study Status
- Completed
Trial Condition(s)
- Multiple Sclerosis
Interventions
- Drug: Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 12/01/2008 - 01/01/2013
Study Type
Observational
